NC Court Rules 65K Voters Have Fifteen Days to Prove Eligibility In Contested...
Who They REALLY Are --> Racist Antifa Members Attack Conservative Black Man at...
USA Fencing Gets Absolutely SKEWERED for Sexist Statement on 'Tolerance' After Expelling F...
Sorry AIN'T Cuttin' It! Rahm Emanuel Says Democrats Made Mistakes on COVID but...
Sunny Hostin Wagers Many Trump Voters Now Wish Harris Had Won (We'll Take...
Leading Lefty Rag BUSTS Republicans for Only Wanting Legal Citizens to Vote (No,...
WATCH What BACKFIRE Looks Like In Real Time As Witness OWNS Amy Klobuchar...
And HERE We Go! AOC Officially Becomes Chuck Schumer's Worst Nightmare annnd We...
For SOME Reason Dems Visiting the Border Decided No Press Access or Public...
Oh, Honey: SE Cupp Is Outraged (OUTRAGED, We Say!) Because Americans DARE Doubt...
Michigan Secretary of State's Claim There's 'No Evidence' of Non-Citizen Voting Aged Badly...
This Is How You Handle Men in Women's Sports
'Defund DEEZ Nuts!' Dem BRAGS About Introducing Legislation to Defund DOGE and WOW,...
Nature Is HEALING: Jobs Report 'by the Numbers' Is GREAT News for Private...
Glenn Beck Gets to the Bottom of Why 'This Judicial Coup Against Trump...

Pfizer delays its EUA request for a 2-dose Covid vaccine for kids under 5, will wait for data on a 3-dose vaccine instead

Pfizer told the FDA on Friday that it wants a delay on the company’s EUA request for a two-dose Covid vaccine for children under five. . .

Advertisement

. . .and that’s because Pfizer thinks three doses “may provide a higher level of protection in this age group”:

Here’s the statement from the FDA:

The U.S. Food and Drug Administration has been notified by Pfizer that new data have recently emerged regarding its emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age. As part of its rolling submission, the company recently notified the agency of additional findings from its ongoing clinical trial. Based on the agency’s preliminary assessment, and to allow more time to evaluate additional data, we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization.

Advertisement

Something just doesn’t add up here, right?

The FDA was going to meet on February 15 to discuss the authorization for this age group:

Pfizer expects to have data from the three-dose vaccine in April:

Advertisement

In other words, “back to the drawing board”:

Do you mean to tell us our health experts have a messaging problem?

***

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos